Articolul precedent |
Articolul urmator |
381 2 |
Ultima descărcare din IBN: 2023-09-15 07:32 |
SM ISO690:2012 CHEPTANARI-BIRTA, Nicoleta, BRUMAREL, Mihail. Aspects regarding risk management in the process of circulation of medicines. In: Cercetarea în biomedicină și sănătate: calitate, excelență și performanță, Ed. 1, 20-22 octombrie 2021, Chişinău. Chișinău, Republica Moldova: 2021, p. 432. ISBN 978-9975-82-223-7 (PDF).. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Cercetarea în biomedicină și sănătate: calitate, excelență și performanță 2021 | ||||||
Conferința "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță" 1, Chişinău, Moldova, 20-22 octombrie 2021 | ||||||
|
||||||
Pag. 432-432 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. The management, storage, release and use of pharmaceuticals are risky operations. Risk management in this field aims at the quality, monitoring, evaluation, verification, control, throughout the circulation of the medicinal product. Objective of the study. Identification, analysis and evaluation of the main risks in the process of circulation of the drug in wholesale and retail distribution networks and its use by the patient. Material and Methods. The analytical method of identifying all components of the complex “drug distribution chain” system was used, then the synthesis to assign the risks to each sequence. As procedures we used documentation and identification of relevant bibliographic resources, questioning, data collection and processing, analysis, data interpretation and modeling. Results. The study identified and described the main risks (43) that may influence the distribution chain, 28 of which were described and evaluated, starting from the evaluation scales proposed by different authors. For the identified risks, the probability of occurrence and the impact were estimated, and graphs were elaborated for each risk class presented and on the total risks. The risks were classified into five classes, depending on the phase where they were identified. Conclusion. Based on the results obtained, a risk management plan has been developed to reduce or eliminate them and reduce negative influences. In the paper we also proposed a functional model, in the form of a block diagram for the drug distribution system. |
||||||
Cuvinte-cheie medicine, Risk, pharmacy, medicament, risc, farmacie |
||||||
|